Abbott ’s FreeStyle Libre 3 continuous glucose monitoring system is now available to eligible patients in the UK thanks to its listing on the NHS Supply Chain Network, the company announced 15 March.
The Libre 3, which is approved for up to 14 days of continuous monitoring, is roughly the size of a £1 coin (two stacked US pennies), making it 70% smaller than the older Libre 2, and the smallest CGM approved in the UK. FreeStyle Libre 3 earned a CE Mark in late 2020
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?